ESTRELLA IMMUNOPHARMA INC
ESLA·297584104·US·Common Stock·Healthcare - Biotechnology-13D/G
ESLA (ESTRELLA IMMUNOPHARMA INC) is held by 14 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($405,417), WELLS FARGO & COMPANY/MN ($280,251), GEODE CAPITAL MANAGEMENT, LLC ($166,933). Net institutional sentiment: Mixed.
14
Holders
Avg rating(2 Elite)
$1.1M
Total Value
53% (20)
Fund Consensus
9 buying - 8 selling
Who's Trading
ActivistARArmistice Capital, LLC10.0%May 15, 2026
InsiderXJXu JiandongBuy $1KOct 7, 2025
InsiderXJXu JiandongBuy $1KSep 22, 2025
InsiderXJXu JiandongBuy $104Sep 11, 2025
13F: Insider & Congress:
Showing 1-20 of 20
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer